Stroke
RSSArticles
Be sure no eligible patient misses new treatment window for stroke
With an expanded treatment window of 4.5 hours, more of your stroke patients are eligible for treatment with tissue plasminogen activator (tPA). Minutes still count, however.Don't miss underlying reason for elder's fall
Fractures were the most common injury (41%) of more than 2 million elders coming to community EDs in 2006 because of fall injuries, says a new report from the Agency for Healthcare Research and Quality (AHRQ).Emergency Medicine Reports - Full February 1, 2010 Issue in Streaming Audio/Downloadable MP3 Format
Complications of Prosthetic Heart Valves in the Emergency Department
More than 100,000 prosthetic heart valves are implanted each year in North America, and another 300,000 are done annually worldwide.Ocular Myasthenia in Seniors: A Case for Treatment
Immunomodulatory therapy reduces the rate of conversion to generalized myasthenia gravis in seniors with pure ocular myasthenia.Neuropathy in Liver Failure
Neuropathy occurs with a high frequency in patients with end-stage liver disease, but rarely causes disability.Pharmacokinetics of IV Immunoglobulins and Outcome in GBS
Fixed dose of IVIg may not be effective in all patients with GBS.What Is Frontotemporal Lobar Degeneration? New Clues Emerge
Two studies have identified a novel inclusion found in a subset of FTLD brains and categorize the clinical entity of the behavioral variant of FTLD, based on anatomical patterns.Clinical Briefs in Primary Care Supplement
Treating Multiple Sclerosis: Why Wait?
Glatiramer acetate significantly delayed the onset of clinically definite multiple sclerosis (MS) in patients having a clinically isolated event and brain lesions consistent with MS.